Osimertinib vs Sitagliptin
Osimertinib vs Sitagliptin: Overview
This comparison examines the pharmacological differences between Osimertinib and Sitagliptin.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Sitagliptin: DPP-4 inhibitor increasing incretin levels.
Pharmacokinetics
Half-life: Osimertinib β 48 hours; Sitagliptin β 12.4 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2; Sitagliptin β C16H15F6N5O.
Molecular Weight: Osimertinib β 499.6050 g/mol; Sitagliptin β 407.3140 g/mol.
Type: Osimertinib β Small molecule; Sitagliptin β Small molecule.